Johns Hopkins Kimmel Cancer Center experts at Sibley Memorial Hospital in Washington, D.C., and Suburban Hospital in Bethesda, Md., have vast expertise in managing all types of pancreatic cancers. Part of the Skip Viragh Center for Pancreatic Cancer, our specialists work for a prominent center in the diagnosis and management of pancreatic cancer, leading other institutions in novel therapies, innovative clinical trials and training the next generation of pancreatic cancer experts.
Our Multidisciplinary Approach
Our fellowship-trained medical and radiation oncologists, and surgeons (Dr. Gabriel Ivey on the right), as well as nurses, radiologists, gastroenterologists and other caregivers, work together to support each patient’s experience. New patients can meet with several specialists during a weekly multidisciplinary clinic, one of the first models of its type to bring all experts together to offer newly diagnosed patients a comprehensive consultation. Our experts also participate in tumor board conferences to discuss patient cases with additional experts at our East Baltimore campus. Each patient participates in forming an individualized care plan that maximizes the opportunity for a successful outcome. Patients also have access to innovative clinical trials.
Novel Treatment Options
Our pancreatic cancer experts offer a range of treatment options, including chemotherapy, radiation and surgery, as well as immunotherapy and novel treatments through clinical trials. Pain management and nutrition counseling also are available for pancreatic cancer patients.
Patients can receive nearly all of their care at locations within the greater Washington region.
Pioneering pancreatic cancer research at the Johns Hopkins Kimmel Cancer Center includes refinements to the Whipple procedure, a complex pancreatic cancer surgery; and the first blueprint for pancreatic cancer that maps all the mutations in known human genes linked to cancer.
Johns Hopkins’ pancreatic cancer researchers have long been working toward new therapies. One in development is a pancreatic cancer vaccine. More recent trials have combined the vaccine with a drug targeting a protein on the surface of pancreas tumor cells. Other work aims to create vaccines tailored to the unique molecular characteristics of each patient’s cancer.
Patient Support Services
Beyond medical treatment, our program has other innovative methods of supporting our patients. See our Center for Patient and Family Services page for information about social work, survivorship, patient navigation, spiritual support and other services, or call 202-537-4107.
- Listen to radiation oncologist Amol Narang, M.D., discuss how he and his colleagues address the challenges of treating pancreatic cancer.
- Listen to oncologist Lei Zheng, M.D., Ph.D., of the Bloomberg~Kimmel Institute for Cancer Immunotherapy discuss his research into how the immune system can be used to respond to pancreatic cancer.